Growth Metrics

RxSight (RXST) Inventory Average (2021 - 2026)

RxSight filings provide 5 years of Inventory Average readings, the most recent being $32.0 million for Q4 2025.

  • On a quarterly basis, Inventory Average rose 44.3% to $32.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $32.0 million, a 44.3% increase, with the full-year FY2025 number at $28.1 million, up 38.52% from a year prior.
  • Inventory Average hit $32.0 million in Q4 2025 for RxSight, up from $27.7 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $32.0 million in Q4 2025 to a low of $8.3 million in Q1 2022.
  • Median Inventory Average over the past 5 years was $18.4 million (2023), compared with a mean of $18.1 million.
  • Biggest five-year swings in Inventory Average: skyrocketed 99.14% in 2023 and later grew 6.32% in 2024.
  • RxSight's Inventory Average stood at $8.7 million in 2021, then skyrocketed by 75.03% to $15.3 million in 2022, then increased by 20.45% to $18.4 million in 2023, then increased by 20.23% to $22.1 million in 2024, then soared by 44.3% to $32.0 million in 2025.
  • The last three reported values for Inventory Average were $32.0 million (Q4 2025), $27.7 million (Q3 2025), and $24.3 million (Q2 2025) per Business Quant data.